Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group; Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.
Fliser D, et al. Among authors: kronenberg f.
J Am Soc Nephrol. 2007 Sep;18(9):2600-8. doi: 10.1681/ASN.2006080936. Epub 2007 Jul 26.
J Am Soc Nephrol. 2007.
PMID: 17656479